| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.22▲ | 1.20▲ | 1.20▲ | 1.17▲ | 1.17▲ |
| MA10 | 1.21▲ | 1.19▲ | 1.18▲ | 1.16▲ | 1.16▲ |
| MA20 | 1.20▲ | 1.18▲ | 1.17▲ | 1.16▲ | 1.28▼ |
| MA50 | 1.18▲ | 1.16▲ | 1.15▲ | 1.16▲ | 1.66▼ |
| MA100 | 1.16▲ | 1.15▲ | 1.15▲ | 1.29▼ | 2.49▼ |
| MA200 | 1.15▲ | 1.16▲ | 1.17▲ | 1.65▼ | 8.12▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | 0.004▲ | 0.006▲ | 0.008▲ | 0.028▲ |
| RSI | 82.171▲ | 83.637▲ | 80.234▲ | 62.526▲ | 44.267▼ |
| STOCH | 90.385▲ | 65.556 | 82.575▲ | 62.465 | 46.620 |
| WILL %R | -7.143▲ | -5.263▲ | -4.762▲ | 0.000▲ | -45.652 |
| CCI | 197.436▲ | 291.386▲ | 217.117▲ | 301.060▲ | 0.892 |
|
Friday, April 17, 2026 11:52 AM
Advancing clinical research while generating positive data is a critical combination in biotechnology, particularly when addressing diseases with limited treatment options. Soligenix (NASDAQ: SNGX) ...
|
|
Friday, April 17, 2026 10:18 AM
Soligenix reports clinical update centered on cutaneous T-cell lymphoma (“CTCL”), a rare form of non-Hodgkin lymphoma that primarily affects the skin. The interim update highlighted that the overall ...
|
|
Monday, April 13, 2026 07:04 PM
Showcased For Smarter Path To Drug Development. Soligenix (NASDAQ: SNGX) was featured in a recent article that discussed its positioning in a landscape where modern biopharmaceutical innovation often ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/04/26 | 1.18 | 1.25 | 1.17 | 1.25 | 565,982 |
| 16/04/26 | 1.13 | 1.18 | 1.13 | 1.17 | 181,412 |
| 15/04/26 | 1.15 | 1.16 | 1.14 | 1.15 | 172,704 |
| 14/04/26 | 1.145 | 1.15 | 1.13 | 1.15 | 93,012 |
| 13/04/26 | 1.10 | 1.16 | 1.10 | 1.15 | 165,271 |
| 10/04/26 | 1.15 | 1.15 | 1.12 | 1.12 | 103,947 |
| 09/04/26 | 1.15 | 1.15 | 1.12 | 1.14 | 161,410 |
| 08/04/26 | 1.14 | 1.15 | 1.13 | 1.15 | 105,949 |
| 07/04/26 | 1.13 | 1.15 | 1.11 | 1.14 | 83,459 |
| 06/04/26 | 1.16 | 1.16 | 1.12 | 1.14 | 136,110 |
|
|
||||
|
|
||||
|
|